EGF and central nervous system cancer: In glioma cells, the epidermal growth factor (EGF)/EGFR signaling through ERK1/2 leads to the phosphorylation of α-catenin, which, together with cadherin, forms a complex linked to the cytoskeleton, promoting β-catenin transactivation and glioma cell invasion [53].